Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia

Leukemia Research

Volumn 32, Issue 11, 2008, Pages 1770-1775

  Pullarkat, Sheeja T ^a   Vardiman, James W ^b   Slovak, Marilyn L ^c   Rao, Dinesh S ^a   Rao, Nagesh P ^a   Bedell, Victoria ^c   Said, Jonathan W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Acute megakaryoblastic leukemia; BCR ABL1; Blast crisis; Chronic myeloid leukemia; Target FISH

Indexed keywords

BCR ABL PROTEIN; CD33 ANTIGEN; CD45 ANTIGEN; CD61 ANTIGEN; CD7 ANTIGEN; FIBRINOGEN RECEPTOR; HEMOGLOBIN; IMATINIB; LACTATE DEHYDROGENASE;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ADULT; ARTICLE; BACTEREMIA; BLAST CELL CRISIS; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKEMIA CELL; LYMPHOCYTE COUNT; MALE; MONOCYTE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NEUTROPHIL COUNT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN LOCALIZATION; THROMBOCYTE COUNT; TRIPLOIDY;

BLAST CRISIS; FUSION PROTEINS, BCR-ABL; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MEGAKARYOBLASTIC, ACUTE; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MEGAKARYOCYTES; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 47249096638     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.02.025     Document Type: Article

References (35)

1. Tallman M.S., Neuberg D., Bennett J.M., et al. Acute megakaryocytic leukemia: the eastern cooperative Oncology Group experience. Blood 96 (2000) 2405-2411
2. Bennett J.M., Catovsky D., Daniel M.T., et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group. Ann Intern Med 103 (1985) 460-462
3. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of myeloid neoplasms. Blood 100 (2002) 2292-2302
4. Nowell P.C., and Hunberford D.A. A minute chromosome in human granulocytic leukemia. Science 132 (1960) 1497-1499
5. Rowley J.D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243 (1973) 290-293
6. Fialkow P.J., Martin P.J., Naifeld V., Penfold G.K., Jacobson R.J., and Hansen J.A. Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 58 (1981) 158-163
7. Faderi S., Talpaz M., Estrov Z., and Kantarjian H.M. Chronic myelogenous leukemia: biology and therapy. Ann Intern Med 131 (1999) 207-219
8. Nair C., Chopra H., Shinde S., et al. Immunophenotype and ultrastructural studies in blast crisis of chronic myeloid leukemia. Leuk Lymphoma 19 (1995) 309-313
9. Bourantas K.L., Repousis P., Tsiara S., Christou L., Konstantinidou P., and Bai M. Chronic myelogenous leukemia terminating in acute megakaryoblastic leukaemia. Case report. J. Exp Clin Cancer Res 17 (1998) 243-245
10. Slovak M.L., Bedell V., Pagel K., Chang K.L., Smith D., and Somlo G. Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype/genotype fluorescence in situ hybridisation. Cancer Genet Cytogenet 158 2 (2005) 99-109
11. Bedell V., Forman S.J., Gaal K., Pullarkar V., Weiss L.M., and Slovak M.L. Successful application of a direct detection slide-based sequential phenotype/genotype assay using archived bone marrow smears and paraffin embedded tissue sections. J Mol Diagn 9 (2007) 589-597
12. Soupir C.P., Vergillo J.A., CIn P.D., et al. Philadelphia chromosome- positive acute myeloid leukaemia. A rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol 127 (2007) 642-650
13. Keung Y.K., Beaty M., Powell B.L., et al. Philadelphia chromosome positive myelodysplastic syndrome and acute myeloid leukemia: retrospective study and review of literature. Leuk Res 28 (2004) 579-586
14. Paietta E., Racevskis J., Bennett J.M., et al. Biological heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia 12 (1998) 181-1885
15. Griesshammer M., Heinze B., Bangerter M., Heimpel Hermann, and Fliedner T.M. Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia. J Mol Med 75 (1997) 836-838
16. Chang H.J., Tien H.F., Wang C.H., et al. Comparison of Clinical and Biological features between myeloid and lymphoid transformation of Philadelphia chromosome positive chronic myeloid leukemia. Cancer Genet Cytogenet 71 (1993) 87-93
17. Tien H.F., Chuang S.M., and Wang C.H. Chromosomal characteristics of Ph-positive chronic myelogenous leukemia in transformation. A study of 23 Chinese patients in Taiwan. Cancer Genet Cytogenet 39 (1989) 89-97
18. Majlis A., Smith T.L., Talpaz M., O'Brien S., Rios M.B., and Kantarjian H.M. Significance of cytogenetic clonal evolution in chronic myelogenous leukaemia. J Clin Oncol 14 (1996) 196-203
19. Calabretta B., and Perrotti D. The biology of blast crisis. Blood 103 (2004) 4010-4022
20. Kantarjian H.M., Keating Mj, Talpaz M., et al. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 83 (1987) 445-454
21. Marktel S., Marin D., Foot N., et al. Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression. Haematologica 88 (2003) 260-267
22. Hirose Y., Masaki Y., Kawabata H., et al. Double Ph- positive megakaryoblastic transformation of chronic myeloid leukaemia. Eur J Haematol 69 (2002) 122-125
23. Williams W.C., and Weiss G.B. Megakaryoblastic transformation of chronic myelogenous leukemia. Cancer 49 (1982) 921-926
24. Lingg G., Schmalzi F., Brenton-Gorius J., et al. Megakaryoblastic micromegakaryocytic crisis in chronic myeloid leukemia. Blood 51 (1985) 275-285
25. Berger R. Differences between blastic chronic myeloid leukemia and Ph-positive acute leukemia. Leuk Lymphoma 11 (1993) 235-237
26. Pelloso L.A.F., Baiocchi O.C.G., Chauffaille M.L.L.F., Yamamoto M., Hungria V.T.M., and Bordin J.O. Megakaryocytic blast crisis as a first presentation of chronic myeloid leukemia. Eur J Haematol 69 (2002) 58-61
27. Wu C.D., Medeiros L.J., Miranda R.N., Mark H.F., and Rintels P. Chronic myeloid leukemia manifested during megakaryoblastic crisis. South Med J 89 (1996) 422-427
28. Campiotti L., Grandi A.M., Biotti M.G., Ultori C., Solbiati F., Codari R., et al. Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia. Am J Hematol 82 (2007) 231-233
29. Bryant B.J., Alperin J.B., and Elghetany M.T. Paraplegia as the presenting manifestation of extramedullary megakaryoblastic transformation of previously undiagnosed chronic myelogenous leukemia. Am J Hematol 82 (2007) 150-154
30. Gimseng P., Overballe-Peterson C., and Hippie E. Cobalamin and cobalamin-binding proteins in plasma related to the clinical condition in chronic myelogenous leukemia. Leukemia 9 (1995) 1604-1609
31. Sawyers C.L., Hochhaus A., Feldman E., et al. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood 99 (2002) 3530-3539
32. Kantarjian H.M., Cortes J., O'Brien S., et al. Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase. Blood 99 (2002) 3547-3553
33. Ito K., Tominaga K., Suzuki T., et al. Successful treatment with imatinib mesylate in a case of minor BCR-ABL positive acute myelogenous leukemia. Int J Hematol 81 (2005) 242-245
34. Yamaguchi M., and Konishi J. Successful treatment with imatinib mesylate for Philadelphia chromosome-positive refractory acute myeloid leukemia. Rinsho Ketsueki 44 (2003) 254-256 [in Japanese]
35. Jentsch-Ullrich K., Pelz A.F., Braun H., et al. Complete molecular remission in a patient with Philadelphia-chromosome positive acute myeloid leukemia after conventional therapy and imatinib. Hematologica 89 (2004) ECR15. http://www.haematologica.org/online/e-cases/2004/5/ecr15/index.htm [available at http://www.haematologica.org/online/e-cases/2004/5/ecr15/index.htm. Accessed May 1, 2006].